LGND AI, Inc. | $9,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)
Bilt | $250,000,000 | (Jul 11, 2025)
Certified by Founder
Lodge
Arpeggio Biosciences
start up
United States
- Boulder, CO
- 08/09/2022
- Series A
- $17,000,000
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
- Industry Biotechnology Research
- Website https://www.arpeggiobio.com/
- LinkedIn https://www.linkedin.com/company/arpeggio-biosciences/
Related People
Joey AzofeifaFounder
United States -
Boulder, Colorado
I work with biologists, mathematicians and computer scientists to build technology that will better our understanding of human disease.
Aqtual, Inc. | $31,000,000 | (Jul 11, 2025)
Knox Systems, Inc. | $6,500,000 | (Jul 11, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Foundation EGI | $23,000,000 | (Jul 11, 2025)
Augmentus Robotics | $11,000,000 | (Jul 11, 2025)
Datafy.io | $20,000,000 | (Jul 11, 2025)
Renasant Bio | $54,500,000 | (Jul 11, 2025)
Supply Wisdom | $14,000,000 | (Jul 10, 2025)